Comparisons

Ozempic vs Rybelsus

Published Sep 12, 2026 · 7 minute read

Same molecule, same disease, two routes. The tablet needs ten times the milligrams, has to be taken on an empty stomach, and was proven in a different trial program.

Medical Supervision Required:Peptide Tracker is for private logging, calculations, reminders, inventory records, and education. It is not medical advice, dosing instruction, prescribing guidance, diagnosis, or a substitute for a qualified healthcare professional.

Key Takeaways

  • Same molecule, both for type 2 diabetes. Ozempic is a weekly injection of 0.25 to 2 mg; Rybelsus is a daily tablet of 3 to 14 mg.
  • A tablet needs roughly ten times the milligrams because only 0.4% to 1% of oral semaglutide is absorbed, per the label, even with the SNAC absorption enhancer.
  • In PIONEER 4, 14 mg oral semaglutide lowered HbA1c by 1.2 points and matched an injected GLP-1, liraglutide 1.8 mg, with more weight loss.
  • The empty-stomach rule is not advice, it is the label: on waking, no more than 4 ounces of water, nothing else for 30 minutes.
  • The brand map has shifted. Ozempic tablets now exist on the Rybelsus label, and a Wegovy tablet exists for weight reduction.
Ozempic Rybelsus
Molecule Semaglutide Semaglutide
Route Weekly subcutaneous injection Daily tablet
Doses 0.25, 0.5, 1, 2 mg 3, 7, 14 mg
Timing rule Any time, with or without food On waking, empty stomach, 4 oz water, 30-minute wait
Trial program SUSTAIN PIONEER
Cardiovascular indication Yes (SUSTAIN-6) No

Why 14 mg by mouth is not 14 mg by injection

Semaglutide is a peptide. Swallowed on its own, stomach acid and enzymes destroy it. The tablet pairs each dose with 300 mg of SNAC, salcaprozate sodium, which raises pH in its immediate vicinity and lets semaglutide cross the stomach lining before it is broken down.

Even so, only 0.4% to 1% of a Rybelsus dose reaches circulation, per the label’s pharmacokinetics section; the newer Ozempic tablets manage 1% to 2%. That is the arithmetic behind the ladders: a 14 mg tablet and a 1 mg injection are two different ways to get a similar amount of drug into the blood. The bioavailability explainer covers the concept.

0.4–1%of a Rybelsus dose is absorbed, per the label, which is why the tablet ladder runs 3 to 14 mg and the injection ladder 0.25 to 2 mg.
4 ozof water, maximum. More water dilutes the SNAC effect and cuts absorption. Coffee and juice are not substitutes.
30 minbefore food, drink, or other oral medicines. Absorption is highest when the stomach is empty and stays that way.

What the trials showed

The two products were never compared directly. Ozempic came from the SUSTAIN program; Rybelsus from PIONEER. The best single PIONEER trial for this page is PIONEER 4, because it put the tablet against an injected GLP-1.

HbA1c reduction with oral semaglutide, PIONEER 4Mean change from baseline at 26 weeks in percentage points, adults with type 2 diabetes on metformin, n=711
Oral semaglutide 14 mgRybelsus dose
Oral semaglutide
1.2 pp
Liraglutide 1.8 mg injectionActive comparator
Liraglutide
1.1 pp
Placebo
Placebo
0.2 pp

Oral semaglutide 14 mg 1.2 points; subcutaneous liraglutide 1.8 mg 1.1 points; placebo 0.2 points. Oral semaglutide was non-inferior to liraglutide and superior to placebo.

Source: Pratley 2019, Lancet

At 26 weeks, oral semaglutide 14 mg was non-inferior to liraglutide 1.8 mg on HbA1c and produced more weight loss: 4.4 kg versus 3.1 kg, against 0.5 kg on placebo. In PIONEER 1, as monotherapy over 26 weeks, placebo-adjusted HbA1c reductions were 0.6, 0.9, and 1.1 points for 3, 7, and 14 mg, and only the 14 mg dose produced meaningful weight loss, 2.3 kg.

The tablet also has headroom that the approved doses do not use. In PIONEER PLUS, 25 and 50 mg tablets beat 14 mg over 52 weeks.

Oral semaglutide dose response, PIONEER PLUSHbA1c reduction at 52 weeks in percentage points, adults with inadequately controlled type 2 diabetes, n=1,606
14 mgApproved Rybelsus maximum
Oral semaglutide
1.5 pp
25 mgInvestigational in diabetes
Oral semaglutide
1.8 pp
50 mgInvestigational
Oral semaglutide
2 pp

14 mg 1.5 points, 25 mg 1.8 points, 50 mg 2.0 points. Only 14 mg is an approved Rybelsus dose.

Source: Aroda 2023, Lancet

Those higher doses are not approved for diabetes. The 25 mg tablet did reach a label, but as Wegovy for weight reduction, where it produced 13.6% mean weight loss over 64 weeks in OASIS 4.

For the injection, SUSTAIN FORTE is the relevant dose comparison: 2 mg beat 1 mg on HbA1c over 40 weeks with about 0.9 kg extra weight loss. And SUSTAIN-6 gave Ozempic a cardiovascular indication, with major events at 6.6% versus 8.9% on placebo. Rybelsus has no such indication.

The dose ladders

Starting step First maintenance dose Maximum
Ozempic 0.25 mg weekly, 4 weeks 0.5 mg 2 mg
Rybelsus 3 mg daily, 30 days 7 mg 14 mg

Both starting steps exist for tolerability, not effect. The 3 mg tablet is not a treatment dose; the label uses it to let the gut adapt before 7 mg. The oral semaglutide label describes moving to the injection at its own 0.5 mg step, and moving from 0.5 mg injection to 7 or 14 mg tablets. It does not convert milligrams across routes.

The empty-stomach rule

The Rybelsus label is unusually specific, because absorption is fragile:

  1. On waking, before anything else.
  2. With no more than 4 ounces of plain water. Not coffee, not juice, not a full glass.
  3. Swallowed whole. Not split, crushed, or chewed.
  4. At least 30 minutes before food, other drinks, or other oral medicines.

Each rule maps to a measured loss of absorption in the pharmacology studies. Ozempic has no food rule at all.

The brand map has moved

Semaglutide brands used to map onto routes: Ozempic and Wegovy injected, Rybelsus swallowed. Two changes broke that.

Ozempic-branded tablets in 1.5, 4, and 9 mg now sit on the same oral semaglutide label as Rybelsus. And the Wegovy label carries a tablet in 1.5, 4, 9, and 25 mg for weight reduction. So there is now an oral Ozempic and an oral Wegovy, on labels other than the injection labels. The oral vs injectable GLP-1 page tracks the broader picture, including orforglipron, the first non-peptide oral GLP-1.

Which comparison you wanted

For the log, the route changes what to record. An injection needs a site; a tablet needs the time relative to breakfast. How GLP-1 tracking works covers both.

7. Ozempic vs Rybelsus FAQ

  • Is Rybelsus as effective as Ozempic?

    They were not compared head-to-head. In its own trials, 14 mg oral semaglutide lowered HbA1c by about 1.1 to 1.2 percentage points and matched injected liraglutide. Ozempic 1 mg lowered HbA1c by about 1.9 points in SUSTAIN FORTE, and 2 mg by more. The labels treat the two as separate products with separate ladders.

  • Why is the Rybelsus dose so much higher in milligrams?

    Absorption. Semaglutide is a peptide and is destroyed in the gut. The tablet pairs it with SNAC, which raises stomach pH locally and lets a small fraction cross the stomach lining. The label's pharmacokinetics section puts absolute bioavailability at 0.4% to 1% for Rybelsus, so 14 mg by mouth delivers something in the range of a 1 mg injection.

  • Can I take Rybelsus with food or coffee?

    The label says no. Take it on waking on an empty stomach with up to 4 ounces of plain water, then wait at least 30 minutes before food, drink, or other oral medicines. Food and larger volumes of water reduce absorption.

  • Can I switch from Rybelsus to Ozempic, or the other way?

    Switching is a prescriber decision. Because the milligram amounts are not equivalent across routes, the oral semaglutide label describes moving to the injection at its own 0.5 mg step rather than converting a dose.

  • Is there an Ozempic pill?

    Ozempic-branded tablets in 1.5, 4, and 9 mg exist, but they sit on the oral semaglutide label alongside Rybelsus, not on the Ozempic injection label. A Wegovy tablet, up to 25 mg, is approved for weight reduction.

8. Sources

References used for this article

Download for iOS